Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Nantahala Capital Management

Investor type Hedge Fund

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$73M
Portfolio companies 7
Lead investments 0
Exits 5
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Medical Device
  • Medical
  • Therapeutics

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Nantahala Capital Management:
Typical Co-investors
Nantahala Capital Management is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Nantahala Capital Management:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Access Ventures China, Hong Kong, Hong Kong Island
American Underground Durham, North Carolina, United States
Aspen Grove Capital Avon, Colorado, United States
BackBone Ventures Switzerland, Zurich, Zurich
Dynegy Houston, Texas, United States
Fast Forward California, San Francisco, United States
Government of Slovak Republic District of Zvolen, Region of Banská Bystrica, Slovakia
Hyundai Mobis Seoul, Seoul-t'ukpyolsi, South Korea
LendingTree Charlotte, North Carolina, United States
Macanta Investments -
Montlake Capital Seattle, United States, Washington
Rebright Partners Chiyoda, Japan
Rhythm VC New York, New York, United States
SamInvest Mitt Härnösands domkyrkodistrikt, Sweden, Västernorrland County
Shenzhen Baodechang Investment China, Guangdong, Shenzhen
South Valley Angels California, Morgan Hill, United States
The Capital Partnership England, London, United Kingdom
Topline Capital California, United States, Villa Park
W.R. Huff Asset Management Co. LLC. Florida, Stuart, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Abeona Therapeutics

Biotechnology
Genetics
Health Care
Medical Device
$35M03 Nov 2022 New York, New York, United States

immatics biotechnologies

Biotechnology
Medical
Therapeutics
$110M10 Oct 2022 Germany, Baden-Württemberg, Germany

Lyra Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
Wellness
$100M08 Apr 2022 Massachusetts, United States

Disc Medicine

Biotechnology
Health Care
Medical
$90M02 Sep 2021 Cambridge, Massachusetts, United States

Keystone Dental

Biopharma
Health Care
Medical Device
$25M01 Sep 2021 Massachusetts, United States

DarioHealth

Cloud Computing
Health Care
Medical Device
Software
$70M27 Jan 2021 New York, United States

Silverback Therapeutics

Biopharma
Biotechnology
Health Care
Medical
Therapeutics
$85M23 Sep 2020 Seattle, Washington, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Nantahala Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: